加州太平洋生物科學公司 PACB 深 滬
已收盤 02-06 16:00:00 美东时间
1.82
+0.105
+6.12%
華盛通- 最 高1.86
- 今 開1.80
- 成交量 713.69万股
- 最 低 1.6925
- 昨 收 1.715
- 總市值 5.49亿
- 52周最高 2.73
- 市盈率 靜 --
- 換手率 2.36%
- 52周最低 0.8511
- 委 比 -64.75%
- 總股本 3.02亿
- 歷史最高 53.69
- 量 比 0.85
- 振 幅 9.77%
- 歷史最低 0.8511
- 每 手 1
- 風險率 0.41%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Pacific Biosciences Announces Interim Leadership Role Realignment
Pacific Biosciences ( ($PACB) ) just unveiled an update. On February 3, 2026, P...
02-04 05:57
Pacific Biosciences tauscht interimistisch Aufgaben zwischen CEO und COO
Pacific Biosciences tauscht interimistisch Aufgaben zwischen CEO und COO Pacific Biosciences of California Inc. hat bekanntgegeben, dass Mark Van Oene, Chief Operating Officer, ab dem 28. Januar 2026 interimistisch die Verantwortung für die Bereiche Vertrieb und Kundensupport übernimmt, die zuvor be
02-04 05:21
Pacific Biosciences Strengthens Balance Sheet via Asset Sale
The latest update is out from Pacific Biosciences ( ($PACB) ). On January 30, 2...
02-02 22:54
Pacific Biosciences of California Inc. to Report Fourth Quarter and Full Year 2025 Financial Results
Pacific Biosciences of California Inc. to Report Fourth Quarter and Full Year 2025 Financial Results Pacific Biosciences of California Inc. will report its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, at 5:00 pm Eastern Time. The results will be discussed durin
01-28 05:05
Pacific Biosciences to collaborate with foundations on rare genetic disease therapies
Pacific Biosciences of California (PACB) will work with the n-Lorem and EspeRare Foundations to use long-read whole-genome sequencing to develop personalized antisense oligonucleotide therapies for ul...
01-13 00:23
PacBio To Employ PacBio HiFi Whole-Genome Sequencing To Probe Sudden Unexplained Death In Childhood
PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced that a UW Medicine and Seattle Children's research effort led by Danny Miller, MD, PhD, and Alexandra Keefe, MD, PhD,
01-12 22:12
PacBio Reports Q4 2025 Revenue Of ~$44.6M; FY25 Revenue Of ~$160M
PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced preliminary unaudited revenue for the fourth quarter of 2025 and full year 2025 of $44.6 million and $160.0
01-12 22:09
夜读 | 2026年美股该如何操作？“木头姐”最新战略揭晓：押注基因编辑，抛售消费科技！
2026年美股该如何操作？“木头姐”最新战略揭晓：押注基因编辑，抛售消费科技，特斯拉仍为最大持仓！布局详情>>
01-05 23:59
Cathie Wood's Biotech Trend: Twist, Beam, CRISPR Latest Stock Picks
The massive rotation currently unfolding within ARK Invest suggests that Cathie Wood thinks 2026 will be the year of the genomic revolution.
01-01 06:06
